Home / Reports


The best selling biotechnology drugs of 2008: the next biosimilars targets

Last updated: 20 September 2013

According to the report Market-Leading Biotechnology Drugs 2009: Blockbuster Dynamics in an Ailing Economy, sales of the top 10 biotech drugs exceeded US$41.5 billion (Euros 28.6 billion) in 2008.

Amgen, Hospira and Sandoz set to dominate US biosimilars market

A new report released by Thomson Reuters on 14 May 2013 identifies Amgen, Hospira and Sandoz as having the greatest potential to dominate the early stages of the biosimilars market in the US.

US places India on IP black list

The US has placed India on a special trade black list of countries that have raised concerns about intellectual property rights.

Use of biosimilars in Europe

Uptake of biosimilars in Europe is slowly increasing, according to a new report published by the European Commission’s (EC) Enterprise and Industry Directorate-General.

EU publishes consensus report on biosimilars

The European Commission’s (EC’s) Enterprise and Industry Directorate-General has published a new report providing comprehensive information on the concept of biosimilars.

More UK patients affected by drug shortages in 2012

The number of UK patients affected by shortages in brand-name medicines has increased during 2012, according to an online survey carried out by pharmacists’ organization Chemist+Druggist (C+D).

Patients in US turn to generics to save money

According to a new report released on 9 April 2013 by the US Centers for Disease Control and Prevention, adults in the US used several strategies to reduce the costs of their medications, including asking their doctor for a lower-cost (generic) medicine.

Huge differences in prescription drug prices in Ireland

A survey carried out by Ireland’s National Consumer Agency (NCA) has found that the price of many commonly prescribed medicines varies widely across Ireland.

Fewer generics approved in the US during 2012

FDA approved fewer generics for the US market during 2012 than in 2011, according to a new report from Thomson Reuters.

India supplies 20% of generic drugs worldwide

Every fifth tablet, capsule and injectable generic drug being used in the world is manufactured in India, according to India’s Health Minister Ghulam Nabi Azad.